From the Food and Drug Administration.

UNITED States. Food & Drug Administration; AGGLUTINATION tests; GRANTS in aid (Public finance); COMMERCIAL products

Presents news related to the activities of the U.S. Food and Drug Administration (FDA). Receipt by the Cambridge Bioscience Corporation of the FDA approval for its Recombigen latex agglutination test kit; Acceptance by the FDA for grant applications to develop orphan products; Efforts of the FDA to reduce the publication cost of 'The Orange Book' by including it in a U.S. Pharmacopoeial drug information literature.